These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28281895)

  • 21. Randomization, matching, and propensity scores in the design and analysis of experimental studies with measured baseline covariates.
    Loux TM
    Stat Med; 2015 Feb; 34(4):558-70. PubMed ID: 25384851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Simulation-Based Comparison of Covariate Adjustment Methods for the Analysis of Randomized Controlled Trials.
    Chaussé P; Liu J; Luta G
    Int J Environ Res Public Health; 2016 Apr; 13(4):414. PubMed ID: 27077870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of covariance in randomized trials: More precision and valid confidence intervals, without model assumptions.
    Wang B; Ogburn EL; Rosenblum M
    Biometrics; 2019 Dec; 75(4):1391-1400. PubMed ID: 31009064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An evaluation of constrained randomization for the design and analysis of group-randomized trials with binary outcomes.
    Li F; Turner EL; Heagerty PJ; Murray DM; Vollmer WM; DeLong ER
    Stat Med; 2017 Oct; 36(24):3791-3806. PubMed ID: 28786223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and non-parametric strategies for addressing them.
    Koch GG; Tangen CM; Jung JW; Amara IA
    Stat Med; 1998 Aug 15-30; 17(15-16):1863-92. PubMed ID: 9749453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weighted re-randomization tests for minimization with unbalanced allocation.
    Han B; Yu M; McEntegart D
    Pharm Stat; 2013; 12(4):243-53. PubMed ID: 23760923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.
    Baker SG; Fitzmaurice GM; Freedman LS; Kramer BS
    Biostatistics; 2006 Jan; 7(1):29-40. PubMed ID: 15923407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How are missing data in covariates handled in observational time-to-event studies in oncology? A systematic review.
    Carroll OU; Morris TP; Keogh RH
    BMC Med Res Methodol; 2020 May; 20(1):134. PubMed ID: 32471366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the repeated measures designs and sample sizes for randomized controlled trials.
    Tango T
    Biostatistics; 2016 Apr; 17(2):334-49. PubMed ID: 26586845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dunnett-type inference in the frailty Cox model with covariates.
    Herberich E; Hothorn T
    Stat Med; 2012 Jan; 31(1):45-55. PubMed ID: 22095770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive design: estimation and inference with censored data in a semiparametric model.
    Shen Y; Cheng Y
    Biostatistics; 2007 Apr; 8(2):306-22. PubMed ID: 16787996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analyzing multiple endpoints in a confirmatory randomized clinical trial-an approach that addresses stratification, missing values, baseline imbalance and multiplicity for strictly ordinal outcomes.
    Sun H; Kawaguchi A; Koch G
    Pharm Stat; 2017 Mar; 16(2):157-166. PubMed ID: 28074600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Handling baselines in repeated measures analyses with missing data at random.
    Dinh P; Yang P
    J Biopharm Stat; 2011 Mar; 21(2):326-41. PubMed ID: 21391005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Choosing covariates in the analysis of clinical trials.
    Beach ML; Meier P
    Control Clin Trials; 1989 Dec; 10(4 Suppl):161S-175S. PubMed ID: 2605965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A calibrated Bayesian method for the stratified proportional hazards model with missing covariates.
    Kim S; Kim JK; Ahn KW
    Lifetime Data Anal; 2022 Apr; 28(2):169-193. PubMed ID: 35034213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complementary nonparametric analysis of covariance for logistic regression in a randomized clinical trial setting.
    Tangen CM; Koch GG
    J Biopharm Stat; 1999 Mar; 9(1):45-66. PubMed ID: 10091909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Empirical likelihood inference in randomized clinical trials.
    Zhang B
    Stat Methods Med Res; 2018 Dec; 27(12):3770-3784. PubMed ID: 28679341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accounting for interactions and complex inter-subject dependency in estimating treatment effect in cluster-randomized trials with missing outcomes.
    Prague M; Wang R; Stephens A; Tchetgen Tchetgen E; DeGruttola V
    Biometrics; 2016 Dec; 72(4):1066-1077. PubMed ID: 27060877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On efficiency of constrained longitudinal data analysis versus longitudinal analysis of covariance.
    Lu K
    Biometrics; 2010 Sep; 66(3):891-6. PubMed ID: 19764951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.